Platelet-activating factor production in stimulated macrophages is down-regulated by concurrently produced prostaglandin E2

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1607-1614

  Yamada, Masateru ^a   Watanabe, Masako ^a   Mue, Suetsugu ^b   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SENDAI NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENYLATE CYCLASE; ADENYLATE CYCLASE ACTIVATOR; APLYSIATOXIN; ARACHIDONIC ACID; BUCLADESINE; CALCIMYCIN; CYCLIC AMP; FORSKOLIN; IBUPROFEN; INDOMETACIN; NAPROXEN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C ACTIVATOR; TELEOCIDIN; THAPSIGARGIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; MALE; NEGATIVE FEEDBACK; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RADIOIMMUNOASSAY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; INDOMETHACIN; MACROPHAGES; MALE; PLATELET ACTIVATING FACTOR; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030440983     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. 2 and acetyl-transferase activities during phagocytosis and ionophore stimulation. J. Biol. Chem. 258: 97-102, 1983.
2. ALI, H., CHRISTENBEN, S. B., FOREMAN, J. C., PIOTROSKI, W. AND THASTRUP, O.: The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br. J. Pharmacol. 85: 705-712, 1985.
3. 1 macrophage-like cells. Biochem. J. 298: 543-551, 1994.
4. BENVENISTE, J.: Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature 249: 581-582, 1974.
5. BLIGH, T. G. AND DYER, W. J.: A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917, 1959.
6. CAMUSSI, G., AGLIETTA, M., MALAVASI, F., TETTA, C., PIACIBELLO, W., SANAVIO, F. AND BUSSOLINO, F.: The release of platelet-activating factor from human endothelial cells in culture. J. Immunol. 131: 2397-2403, 1983.
7. COLEMAN, R. A., KENNEDY, I. AND SHELDRICK, R. L. G.: AH6809 a prostanoid EP1-receptor blocking drug. Br. J. Pharmacol. 85: 273P, 1985.
8. 2 sensitive (EP-) receptor. Br. J. Pharmacol. 91: 323P, 1987.
9. COLEMAN, R. A., GRIX, S. P., HEAD, S. A., LOUTTTI, J. B., MALLRTT, A. AND SHELBRICK, R. L. G.: A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47: 151-168, 1994.
10. DRAPIES, J. C., ROUBIN, R., PETIT, J. F. AND BENVENISTE, J.: Lipid mediator synthesis in peritoneal macrophages from mice injected with immunostimulants. Biochem. Biophys. Res. Commun. 751: 90-98, 1983.
11. FONTEH, A. N., WINKLER, J. D., TORPHY, T. J., HERAVI, J., UNDEM, B. J. AND CHILTON, F. H.: Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil. J. Immunol. 151: 339-350, 1993.
12. FUJIKI, H., SUGANUMA, M., TAHIRA, T., YOSHIOKA, A., NAKAYASU, M., ENDO, Y., SHUDO, K., TAKAYAMA, S., MOORE, R. E. AND SUGIMURA, T.: New classes of tumor promoters: Teleocidin, aplysiatoxin, and palytoxin. In Cellular Interactions by Environmental Tumor Promoters, ed. by H. Fujiki, E. Hecker, R. W. Moore, T. Sugimura and I. B. Weinstein, pp. 37-45, Japan Sci. Soc. Press, Tokyo/VNU Science Press, Utrecht, 1984.
13. GEMSA, D., STEGGEMANN, L., MENZEL, J. AND TILL, G.: Release of cyclic AMP from macrophages by stimulation with prostaglandins. J. Immunol. 114: 1422-1424, 1975.
14. 2. J. Biol. Chem. 265: 8658-8664, 1990.
15. HANAHAN, D. J., DEMOPOULUS, C. A., LIEHR, J. AND PINCKARD, R. N.: Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J. Biol. Chem. 255: 5514-5516, 1980.
16. HENSON, P. M.: Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion. J. Clin. Invest. 60: 481-490, 1977.
17. HENSON, P. M. AND OADES, Z. G.: Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion. J. Exp. Med. 143: 953-968, 1976.
18. HUMPHREY, D. M., HANAHAN, D. J. AND PINCKARD, R. N.: Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine. Lab. Invest. 47: 227-234, 1982a.
19. HUMPHREY, D. M., MCMANUS, L. M., SATOUCHI, K., HANAHAN, D. J. AND PINCKARD, R. N.: Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. Lab. Invest. 46: 422-427, 1982b.
20. HUMPHREY, D. M., MCMANUS, L. M., HANAHAN, D. J., PINCKARD, R. N.: Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphoryl choline. Lab. Invest. 50: 16-25, 1984.
21. KIMANI, G., TONNESEN, M. G. AND HENSON, P. M.: Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J. Immunol. 140: 3161-3166, 1988.
22. KROEGEL, C., YUKAWA, T., DENT, G., VENGE, P., CHUNG, K. F. AND BARNES, P. J.: Stimulation of degranulation from human eosinophils by platelet-activating factor. J. Immunol. 142: 3518-3526, 1989.
23. 2 and cAMP. J. Immunol. 141: 587-591, 1988.
24. LYNCH, J. M., LOTNER, G. Z., BETZ, S. J. AND HENSON, P. M.: The release of platelet-activating factor by stimulated rabbit neutrophils. J. Immunol. 123: 1219-1226, 1979.
25. MALAVAS, F., TETTA, C., FURANO, A., BELLONE, G., FERRERO, E., FRANZONE, A. C., DELLABONA, P., RUSCI, R., MATERA, L., CAMUSSI, G. AND GALIGARIS-CAPPIO, F.: Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. Proc Natl. Acad. Sci. U.S.A. 83: 2443-2447, 1986.
26. MCMANAUS, L. M., HANAHAN, D. J. AND PINCKARD, R. N.: Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J. Clin. Invest. 67: 903-906, 1981.
27. MENCIA-HUERTA, J. M. AND BENVENISTE, J.: Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur. J. Immunol. 9: 409-415, 1979.
28. MORLEY, J., PAGE, C. P. AND PAUL, W.: Inflammatory actions of platelet-activating factor (Paf-acetherJ in guinea-pig skin. Br. J. Pharmacol. 80: 503-509, 1983.
29. NIETO, M. L., VENABLE, M. E., BAULDRY, S. A., GREENE, D. G., KENNEDY, M., BASS, D. A. AND WYKLE, R. L.: Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction. J. Biol. Chem. 266: 18699-18706, 1991.
30. NINIO, E., MENCIA-HUERTA, J. M. AND BENVEBISTE, J.: Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187. Biochim. Biophys. Acta 751: 298-301, 1983.
31. NINIO, E., MENCIA-HUERTA, J. M., HERMANS, F. AND BENVENISTE, J.: Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. Biochim. Biophys. Acta 710: 23-31, 1982.
32. NISHIZUKA, Y.: Intracellular signaling by hydrolysis of phoepholipide and activation of protein Kinase C. Science 258: 607-614, 1992.
33. O'FLAHERTY, J. T., MILLER, C. H., LEWIS, J. C., WYKLE, R. L., BASS, D. A., MCCALL, C. E., WAITE, M. AND DECHATELET, L. R.: Neutrophil responses to platelet-activating factor. Inflammation 5: 193-201, 1981.
34. OHUCHI, K., SUGAWARA, T., WATANABE, M., HIRASAWA, N., TSURUFUJI, S., FUJIKI, H., CHRISTENSEN, S. B. AND SUGIMURA, T.: Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumor promoters, on arachidonic acid metabolism in rat peritoneal macrophages. Br. J. Pharmacol. 94: 917-923, 1988.
35. OHUCHI, K., SUGAWARA, T., WATANABE, M., HIRASAWA, N., TSURUFUJI, S., FUJIKI, H., SUGIMURA, T. AND CHRISTENSEN, S. B.: Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol 13-acetate) (TPA)-type tumor promoter. J. Cancer Res. Clin. Oncol. 113: 319-324, 1987.
36. 2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide. Biochim. Biophys. Acta 834: 42-47, 1985.
37. PRESCOTT, S. M., ZIMMERMAN, G. A. AND MCINTYRE, T. M.: Human endothelial cells in culture produce platelet activating factor (1-alkyl-2-acetyl-snglycero-3-phosphocholine) when stimulated with thrombin. Proc. Natl. Acad. Sci. U.S.A. 81: 3534-3538, 1984.
38. 2+-ATPaSe inhibitor thapeigargin. J. Biol. Chem. 268: 24751-24757, 1993.
39. ROZENGURT, E., STROOBANT, P., WATERFIELD, M. D., DEUEL, T. F. AND KEEHAN, M.: Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: Role of prostaglandin production. Cell 34: 265-272, 1983.
40. SCHULTS, R. M., STOYCHKOV, J. N., PAVLIDID, N., CHIRIGOS, M. A. AND OLKOWSKI, Z. L.: Role of E-type prostaglandins in the regulation of interferon-treated macrophage cytotoxic activity. J. Reticuloendothel. Soc. 26: 93-102, 1979.
41. SHAW, J. O., PINCKARD, R. N., FERRIGNI, K. S., MCMANUS, L. M. AND HANAHAN, D. J.: Activation of human neutrophils with 1-O-hexadecyl/oetadecyl-2-acetyl-sn-glycerol-3-phosphocholine (platelet activating factor). J. Immunol. 127: 1250-1255, 1981.
42. STIMULER, N. P., BLOOR, C. M., HUGLI, T. E., WYKLE, R. L., MCCALL, C. E. AND O'FLAHERTY, J. T.: Anaphylactic actions of platelet-activating factor. Am. J. Pathol. 105: 64-69, 1981.
43. TESSNER, T. G., GREENE, D. G. AND WYKLE, R. L.: Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils. J. Biol. Chem. 265: 21032-21038, 1990.
44. WATANABE, M., ARAKIDA, Y., TANABE, J., SUGIDACHI, A., HIRASAWA, N., MUE, S. AND OHUCHI, K.: Pharmacological analysis of neutrophil chemotactic factor production by leukocytes and roles of PAF in allergic inflammation in rats. Br. J. Pharmacol. 111: 123-130, 1994.
45. WATANABE, M., SUGIDACHI, S., OMATA, S., HIHASAWA, N., MUE, S., TSURUFUJI, S. AND OHUCHI, K: Possible role for platelet-activating factor in neutrophil infiltration in allergic inflammation in rats. Int. Arch. Allergy Appl. Immunol. 92: 396-403, 1990.
46. WATANABE, M., WATANABE, T., HIRASAWA, N., MUE, S., MURAMATSU, S., MATSUSHITA, Y., TAKAHAGI, H., BTAQUET, P., BROQUET, P., LEVINE, L. AND OHUCHI, K.: Preparation of immunoaffinity mini-columns for the analysis of platelet activating factor (PAF) in biological samples. J. Chromatogr. 597: 309-314, 1992.
47. 2-induced activation of adenosine 3′-5′ cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1). J. Immunol. 139: 3416-3421, 1987.